A. George Scangos's Insider Trades & SAST Disclosures
A. George Scangos's most recent trade in Agilent Technologies Inc. was a trade of 1,819 Common Stock done at an average price of $121.2 . Disclosure was reported to the exchange on March 14, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern A. George Scangos.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Agilent Technologies Inc. | George A. Scangos | Director | Grant, award, or other acquisition of securities at price $ 121.18 per share. | 14 Mar 2025 | 1,819 | 20,493 (0%) | 0% | 121.2 | 220,426 | Common Stock |
| Vir Biotechnology Inc | George A. Scangos | Director | Sale of securities on an exchange or to another person at price $ 9.45 per share. | 24 Feb 2025 | 10,056 | 698,239 (0%) | 0% | 9.5 | 95,063 | Common Stock |
| Vir Biotechnology Inc | George A. Scangos | Director | Sale of securities on an exchange or to another person at price $ 9.81 per share. | 18 Feb 2025 | 10,964 | 708,295 (0%) | 0% | 9.8 | 107,575 | Common Stock |
| Vir Biotechnology Inc | George A. Scangos | Director | Other type of transaction at price $ 0.00 per share. | 23 Oct 2024 | 598,270 | 598,270 (0%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | George A. Scangos | Director | Other type of transaction at price $ 0.00 per share. | 23 Oct 2024 | 598,270 | 719,259 (0%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | George A. Scangos | Director | Other type of transaction at price $ 0.00 per share. | 23 Oct 2024 | 598,270 | 1,151,730 (1%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | George A. Scangos | Director | Other type of transaction at price $ 0.00 per share. | 23 Oct 2024 | 598,270 | 1,151,730 (1%) | 0% | 0 | Common Stock | |
| Voyager Therapeutics Inc | George A. Scangos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 24,000 | 24,000 | - | - | Stock Option (Right to Buy) | |
| Vir Biotechnology Inc | George A. Scangos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 16,000 | 16,000 | - | - | Stock Option (Right to Buy) | |
| Vir Biotechnology Inc | George A. Scangos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 8,000 | 120,989 (0%) | 0% | 0 | Common Stock | |
| Agilent Technologies Inc. | George A. Scangos | Director | Gift of securities by or to the insider at price $ 145.48 per share. | 29 May 2024 | 3,443 | 18,577 (0%) | 0% | 145.5 | 500,888 | Common Stock |
| Agilent Technologies Inc. | George A. Scangos | Director | Gift of securities by or to the insider at price $ 145.48 per share. | 29 May 2024 | 3,443 | 17,893 (0%) | 0% | 145.5 | 500,888 | Common Stock |
| Agilent Technologies Inc. | George A. Scangos | Director | Grant, award, or other acquisition of securities at price $ 147.48 per share. | 15 Mar 2024 | 1,678 | 21,989 (0%) | 0% | 147.5 | 247,471 | Common Stock |
| Vir Biotechnology Inc | A. George Scangos | Director | Sale of securities on an exchange or to another person at price $ 11.65 per share. | 22 Feb 2024 | 17,722 | 112,989 (0%) | 0% | 11.7 | 206,522 | Common Stock |
| Vir Biotechnology Inc | Scangos A. George | Director | Sale of securities on an exchange or to another person at price $ 10.05 per share. | 22 Feb 2024 | 10,028 | 130,711 (0%) | 0% | 10.0 | 100,737 | Common Stock |
| Vir Biotechnology Inc | Scangos George A. | Director | Sale of securities on an exchange or to another person at price $ 10.22 per share. | 16 Feb 2024 | 16,872 | 140,739 (0%) | 0% | 10.2 | 172,385 | Common Stock |
| Vir Biotechnology Inc | A. George Scangos | Director | Sale of securities on an exchange or to another person at price $ 10.24 per share. | 16 Feb 2024 | 10,878 | 157,611 (0%) | 0% | 10.2 | 111,386 | Common Stock |
| Voyager Therapeutics Inc | George A. Scangos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
| Voyager Therapeutics Inc | George A. Scangos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2023 | 44,000 | 44,000 | - | - | Stock Option (Right to Buy) | |
| Agilent Technologies Inc. | George A. Scangos | Director | Grant, award, or other acquisition of securities at price $ 136.82 per share. | 16 Mar 2023 | 1,658 | 20,184 (0%) | 0% | 136.8 | 226,848 | Common Stock |
| Vir Biotechnology Inc | George A. Scangos | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 25.97 per share. | 23 Feb 2023 | 12,631 | 183,608 (0%) | 0% | 26.0 | 328,065 | Common Stock |
| Vir Biotechnology Inc | George A. Scangos | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 23.56 per share. | 23 Feb 2023 | 10,880 | 168,489 (0%) | 0% | 23.6 | 256,300 | Common Stock |
| Vir Biotechnology Inc | George A. Scangos | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 22.74 per share. | 23 Feb 2023 | 4,239 | 179,369 (0%) | 0% | 22.7 | 96,382 | Common Stock |
| Vir Biotechnology Inc | George A. Scangos | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 17 Feb 2023 | 64,930 | 179,930 (0%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | George A. Scangos | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 17 Feb 2023 | 64,930 | 3,533,629 (3%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | George A. Scangos | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 17 Feb 2023 | 49,984 | 111,644 (0%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | George A. Scangos | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 17 Feb 2023 | 49,984 | 111,644 (0%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | George A. Scangos | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 17 Feb 2023 | 49,984 | 827,151 (0%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | George A. Scangos | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 17 Feb 2023 | 49,984 | 827,151 (0%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | George A. Scangos | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 28.02 per share. | 17 Feb 2023 | 11,382 | 202,713 (0%) | 0% | 28.0 | 318,867 | Common Stock |
| Vir Biotechnology Inc | George A. Scangos | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 25.29 per share. | 17 Feb 2023 | 9,894 | 214,095 (0%) | 0% | 25.3 | 250,199 | Common Stock |
| Vir Biotechnology Inc | George A. Scangos | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 28.80 per share. | 17 Feb 2023 | 6,474 | 196,239 (0%) | 0% | 28.8 | 186,451 | Common Stock |
| Agilent Technologies Inc. | George A. Scangos | Director | Grant, award, or other acquisition of securities at price $ 136.82 per share. | 17 Mar 2022 | 1,785 | 18,419 (0%) | 0% | 136.8 | 244,224 | Common Stock |
| Vir Biotechnology Inc | George A. Scangos | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2022 | 222,000 | 222,000 | - | - | Stock Option (Right to Buy) | |
| Vir Biotechnology Inc | George A. Scangos | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2022 | 111,000 | 223,989 (0%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | George A. Scangos | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 30.65 per share. | 17 Feb 2022 | 17,726 | 112,989 (0%) | 0% | 30.7 | 543,304 | Common Stock |
| Vir Biotechnology Inc | George A. Scangos | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 31.93 per share. | 17 Feb 2022 | 10,024 | 130,715 (0%) | 0% | 31.9 | 320,074 | Common Stock |
| Agilent Technologies Inc. | George A. Scangos | Director | Grant, award, or other acquisition of securities at price $ 121.59 per share. | 18 Mar 2021 | 1,850 | 15,557 (0%) | 0% | 121.6 | 224,947 | Common Stock |
| Agilent Technologies Inc. | George A. Scangos | Director | Grant, award, or other acquisition of securities at price $ 121.59 per share. | 18 Mar 2021 | 986 | 16,543 (0%) | 0% | 121.6 | 119,891 | Common Stock |
| Vir Biotechnology Inc | George A. Scangos | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 222,000 | 222,000 | - | - | Stock Option (Right to Buy) | |
| Vir Biotechnology Inc | George A. Scangos | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 111,000 | 4,609,559 (4%) | 0% | 0 | Common Stock | |
| Agilent Technologies Inc. | George A. Scangos | Director | Grant, award, or other acquisition of securities at price $ 93.91 per share. | 03 Aug 2020 | 177 | 28,112 (0%) | 0% | 93.9 | 16,622 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges